aluates Reports

$ 0.0

Automative

Global Anti-inflammatory Agents Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: November 2025

Report Code: QYRE-Auto-10U17234

Global Anti inflammatory Agents Market Research Report 2024

BUY CHAPTERS

Global Anti-inflammatory Agents Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-10U17234

Report

November 2025

Pages:129

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Thermo Fisher Scientific Inc

ORACLE CORPORATION

Revvity

Clario

Illumina Inc

Qiagen NV

Agilent Technologies Inc

IBM Corporation

Genedata Ag

DNAnexus

Anti-inflammatory Agents Market Size

The global Anti-inflammatory Agents market is projected to grow from US$ 102240 million in 2024 to US$ 134020 million by 2031, at a CAGR of 4.0% (2025-2031), driven by critical product segments and diverse end‑use applications.

Anti-inflammatory Agents Market

Anti-inflammatory agents block certain substances in the body that cause inflammation. They are used to treat many different conditions such as treat migraines, headaches, rheumatic arthritis, sprains, and menstrual pain. Furthermore, some anti-inflammatory agents such as celecoxib and ibuprofen are being studied for the prevention and treatment of cancer. In addition, they can provide faster relief as compared to other drugs. They are capable of lowering the levels of prostaglandins and the chemicals responsible for inflammation, thereby reducing pain and swelling. Anti-inflammatory drugs usually target the anti-inflammatory mediators or enzymes. These drugs are often used in combination of other drugs. Inflammation is the most prevalent treatable symptom among many immune and respiratory diseases.

The growth of the global anti-inflammatory agents market has been driven by factors such as increase in prevalence of autoimmune & respiratory conditions, new drugs in pipeline, and surge in adoption of anti-inflammatory drugs. Furthermore, the demand for anti-inflammatory drugs has been increasing exponentially, owing to the emergence of anti-inflammatory biologics that are more targeted, effective, and with lesser side effects as compared to conventional drugs. Moreover, rise in awareness of anti-inflammatory therapeutics and attractive government initiatives toward the treatment of inflammation with nonsteroidal anti-inflammatory drugs in Asia-Pacific and LAMEA are expected to drive the market growth during the analysis period. However, factors such as side effects of anti-inflammatory drugs and patent expiry issues of blockbuster drugs (such as Remicade) impede the market growth.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Anti-inflammatory Agents market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Anti-inflammatory Agents Market Report

Report Metric	Details
Report Name	Anti-inflammatory Agents Market
Accounted market size in 2024	US$ 102240 million
Forecasted market size in 2031	US$ 134020 million
CAGR	4.0%
Base Year	2024
Forecasted years	2025 - 2031
Segment by Type	Software Services
Segment by Application	Pharmaceutical and Biotechnology Companies Contract Research and Development Organizations Others
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher Scientific Inc, Oracle Corporation, Revvity, Inc, Clario, Illumina, Inc, Qiagen NV, Agilent Technologies, Inc, IBM Corporation, Genedata AG, DNAnexus, Inc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Anti-inflammatory Agents study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Anti-inflammatory Agents Market growing?

Ans: The Anti-inflammatory Agents Market witnessing a CAGR of 4.0% during the forecast period 2025-2031.

What is the Anti-inflammatory Agents Market size in 2031?

Ans: The Anti-inflammatory Agents Market size in 2031 will be US$ 134020 million.

Who are the main players in the Anti-inflammatory Agents Market report?

Ans: The main players in the Anti-inflammatory Agents Market are Thermo Fisher Scientific Inc, Oracle Corporation, Revvity, Inc, Clario, Illumina, Inc, Qiagen NV, Agilent Technologies, Inc, IBM Corporation, Genedata AG, DNAnexus, Inc

What are the Application segmentation covered in the Anti-inflammatory Agents Market report?

Ans: The Applications covered in the Anti-inflammatory Agents Market report are Pharmaceutical and Biotechnology Companies, Contract Research and Development Organizations, Others

What are the Type segmentation covered in the Anti-inflammatory Agents Market report?

Ans: The Types covered in the Anti-inflammatory Agents Market report are Software, Services

1 Study Coverage

1.1 Introduction to Anti-inflammatory Agents: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Anti-inflammatory Agents Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Software

1.2.3 Services

1.3 Market Segmentation by Application

1.3.1 Global Anti-inflammatory Agents Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Pharmaceutical and Biotechnology Companies

1.3.3 Contract Research and Development Organizations

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Anti-inflammatory Agents Revenue Estimates and Forecasts 2020-2031

2.2 Global Anti-inflammatory Agents Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020-2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competition by Players

3.1 Global Anti-inflammatory Agents Player Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2020-2025)

3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Player (2020 VS 2024)

3.2 Global Anti-inflammatory Agents Companies Headquarters and Service Footprint

3.3 Main Product Type Market Size by Players

3.3.1 Software Market Size by Players

3.3.2 Services Market Size by Players

3.4 Global Anti-inflammatory Agents Market Concentration and Dynamics

3.4.1 Global Market Concentration (CR5 and HHI)

3.4.2 Entrant/Exit Impact Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Anti-inflammatory Agents Revenue Trends by Type

4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.1.2 Global Revenue Market Share by Type (2020-2031)

4.2 Key Product Attributes and Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Anti-inflammatory Agents Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.1.2 Revenue Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

6 North America

6.1 North America Market Size (2020-2031)

6.2 North America Key Players Revenue in 2024

6.3 North America Anti-inflammatory Agents Market Size by Type (2020-2031)

6.4 North America Anti-inflammatory Agents Market Size by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Anti-inflammatory Agents Market Size by Country

6.6.1 North America Revenue Trends by Country

6.6.2 US

6.6.3 Canada

6.6.4 Mexico

7 Europe

7.1 Europe Market Size (2020-2031)

7.2 Europe Key Players Revenue in 2024

7.3 Europe Anti-inflammatory Agents Market Size by Type (2020-2031)

7.4 Europe Anti-inflammatory Agents Market Size by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Anti-inflammatory Agents Market Size by Country

7.6.1 Europe Revenue Trends by Country

7.6.2 Germany

7.6.3 France

7.6.4 U.K.

7.6.5 Italy

7.6.6 Russia

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2020-2031)

8.2 Asia-Pacific Key Players Revenue in 2024

8.3 Asia-Pacific Anti-inflammatory Agents Market Size by Type (2020-2031)

8.4 Asia-Pacific Anti-inflammatory Agents Market Size by Application (2020-2031)

8.5 Asia-Pacific Growth Accelerators and Market Barriers

8.6 Asia-Pacific Anti-inflammatory Agents Market Size by Region

8.6.1 Asia-Pacific Revenue Trends by Region

8.7 China

8.8 Japan

8.9 South Korea

8.10 Australia

8.11 India

8.12 Southeast Asia

8.12.1 Indonesia

8.12.2 Vietnam

8.12.3 Malaysia

8.12.4 Philippines

8.12.5 Singapore

9 Central and South America

9.1 Central and South America Market Size (2020-2031)

9.2 Central and South America Key Players Revenue in 2024

9.3 Central and South America Anti-inflammatory Agents Market Size by Type (2020-2031)

9.4 Central and South America Anti-inflammatory Agents Market Size by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Anti-inflammatory Agents Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2020-2031)

10.2 Middle East and Africa Key Players Revenue in 2024

10.3 Middle East and Africa Anti-inflammatory Agents Market Size by Type (2020-2031)

10.4 Middle East and Africa Anti-inflammatory Agents Market Size by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Anti-inflammatory Agents Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Israel

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Thermo Fisher Scientific Inc

11.1.1 Thermo Fisher Scientific Inc Corporation Information

11.1.2 Thermo Fisher Scientific Inc Business Overview

11.1.3 Thermo Fisher Scientific Inc Anti-inflammatory Agents Product Features and Attributes

11.1.4 Thermo Fisher Scientific Inc Anti-inflammatory Agents Revenue and Gross Margin (2020-2025)

11.1.5 Thermo Fisher Scientific Inc Anti-inflammatory Agents Revenue by Product in 2024

11.1.6 Thermo Fisher Scientific Inc Anti-inflammatory Agents Revenue by Application in 2024

11.1.7 Thermo Fisher Scientific Inc Anti-inflammatory Agents Revenue by Geographic Area in 2024

11.1.8 Thermo Fisher Scientific Inc Anti-inflammatory Agents SWOT Analysis

11.1.9 Thermo Fisher Scientific Inc Recent Developments

11.2 Oracle Corporation

11.2.1 Oracle Corporation Corporation Information

11.2.2 Oracle Corporation Business Overview

11.2.3 Oracle Corporation Anti-inflammatory Agents Product Features and Attributes

11.2.4 Oracle Corporation Anti-inflammatory Agents Revenue and Gross Margin (2020-2025)

11.2.5 Oracle Corporation Anti-inflammatory Agents Revenue by Product in 2024

11.2.6 Oracle Corporation Anti-inflammatory Agents Revenue by Application in 2024

11.2.7 Oracle Corporation Anti-inflammatory Agents Revenue by Geographic Area in 2024

11.2.8 Oracle Corporation Anti-inflammatory Agents SWOT Analysis

11.2.9 Oracle Corporation Recent Developments

11.3 Revvity, Inc

11.3.1 Revvity, Inc Corporation Information

11.3.2 Revvity, Inc Business Overview

11.3.3 Revvity, Inc Anti-inflammatory Agents Product Features and Attributes

11.3.4 Revvity, Inc Anti-inflammatory Agents Revenue and Gross Margin (2020-2025)

11.3.5 Revvity, Inc Anti-inflammatory Agents Revenue by Product in 2024

11.3.6 Revvity, Inc Anti-inflammatory Agents Revenue by Application in 2024

11.3.7 Revvity, Inc Anti-inflammatory Agents Revenue by Geographic Area in 2024

11.3.8 Revvity, Inc Anti-inflammatory Agents SWOT Analysis

11.3.9 Revvity, Inc Recent Developments

11.4 Clario

11.4.1 Clario Corporation Information

11.4.2 Clario Business Overview

11.4.3 Clario Anti-inflammatory Agents Product Features and Attributes

11.4.4 Clario Anti-inflammatory Agents Revenue and Gross Margin (2020-2025)

11.4.5 Clario Anti-inflammatory Agents Revenue by Product in 2024

11.4.6 Clario Anti-inflammatory Agents Revenue by Application in 2024

11.4.7 Clario Anti-inflammatory Agents Revenue by Geographic Area in 2024

11.4.8 Clario Anti-inflammatory Agents SWOT Analysis

11.4.9 Clario Recent Developments

11.5 Illumina, Inc

11.5.1 Illumina, Inc Corporation Information

11.5.2 Illumina, Inc Business Overview

11.5.3 Illumina, Inc Anti-inflammatory Agents Product Features and Attributes

11.5.4 Illumina, Inc Anti-inflammatory Agents Revenue and Gross Margin (2020-2025)

11.5.5 Illumina, Inc Anti-inflammatory Agents Revenue by Product in 2024

11.5.6 Illumina, Inc Anti-inflammatory Agents Revenue by Application in 2024

11.5.7 Illumina, Inc Anti-inflammatory Agents Revenue by Geographic Area in 2024

11.5.8 Illumina, Inc Anti-inflammatory Agents SWOT Analysis

11.5.9 Illumina, Inc Recent Developments

11.6 Qiagen NV

11.6.1 Qiagen NV Corporation Information

11.6.2 Qiagen NV Business Overview

11.6.3 Qiagen NV Anti-inflammatory Agents Product Features and Attributes

11.6.4 Qiagen NV Anti-inflammatory Agents Revenue and Gross Margin (2020-2025)

11.6.5 Qiagen NV Recent Developments

11.7 Agilent Technologies, Inc

11.7.1 Agilent Technologies, Inc Corporation Information

11.7.2 Agilent Technologies, Inc Business Overview

11.7.3 Agilent Technologies, Inc Anti-inflammatory Agents Product Features and Attributes

11.7.4 Agilent Technologies, Inc Anti-inflammatory Agents Revenue and Gross Margin (2020-2025)

11.7.5 Agilent Technologies, Inc Recent Developments

11.8 IBM Corporation

11.8.1 IBM Corporation Corporation Information

11.8.2 IBM Corporation Business Overview

11.8.3 IBM Corporation Anti-inflammatory Agents Product Features and Attributes

11.8.4 IBM Corporation Anti-inflammatory Agents Revenue and Gross Margin (2020-2025)

11.8.5 IBM Corporation Recent Developments

11.9 Genedata AG

11.9.1 Genedata AG Corporation Information

11.9.2 Genedata AG Business Overview

11.9.3 Genedata AG Anti-inflammatory Agents Product Features and Attributes

11.9.4 Genedata AG Anti-inflammatory Agents Revenue and Gross Margin (2020-2025)

11.9.5 Genedata AG Recent Developments

11.10 DNAnexus, Inc

11.10.1 DNAnexus, Inc Corporation Information

11.10.2 DNAnexus, Inc Business Overview

11.10.3 DNAnexus, Inc Anti-inflammatory Agents Product Features and Attributes

11.10.4 DNAnexus, Inc Anti-inflammatory Agents Revenue and Gross Margin (2020-2025)

11.10.5 Company Ten Recent Developments

12 Anti-inflammatory AgentsIndustry Chain Analysis

12.1 Anti-inflammatory Agents Industry Chain

12.2 Upstream Analysis

12.2.1 Upstream Key Suppliers

12.3 Middlestream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Anti-inflammatory Agents Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Anti-inflammatory Agents Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Thermo Fisher Scientific Inc

ORACLE CORPORATION

Revvity

Clario

Illumina Inc

Qiagen NV

Agilent Technologies Inc

IBM Corporation

Genedata Ag

DNAnexus

List of Tables

Table 1. Global Anti-inflammatory Agents Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Anti-inflammatory Agents Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Anti-inflammatory Agents Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Anti-inflammatory Agents Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Anti-inflammatory Agents Revenue by Region (2026-2031) & (US$ Million)

Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 7. Global Anti-inflammatory Agents Revenue by Players (2020-2025) & (US$ Million)

Table 8. Global Anti-inflammatory Agents Revenue Market Share by Players (2020-2025)

Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 10. Global Anti-inflammatory Agents by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Agents as of 2024)

Table 11. Global Anti-inflammatory Agents Average Gross Margin (%) by Player (2020 VS 2024)

Table 12. Global Anti-inflammatory Agents Companies Headquarters

Table 13. Global Anti-inflammatory Agents Market Concentration Ratio (CR5 and HHI)

Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 16. Global Anti-inflammatory Agents Revenue by Type (2020-2025) & (US$ Million)

Table 17. Global Anti-inflammatory Agents Revenue by Type (2026-2031) & (US$ Million)

Table 18. Key Product Attributes and Differentiation

Table 19. Global Anti-inflammatory Agents Revenue by Application (2020-2025) & (US$ Million)

Table 20. Global Anti-inflammatory Agents Revenue by Application (2026-2031) & (US$ Million)

Table 21. Anti-inflammatory Agents High-Growth Sectors Demand CAGR (2024-2031)

Table 22. Top Customers by Region

Table 23. Top Customers by Application

Table 24. North America Anti-inflammatory Agents Growth Accelerators and Market Barriers

Table 25. North America Anti-inflammatory Agents Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 26. Europe Anti-inflammatory Agents Growth Accelerators and Market Barriers

Table 27. Europe Anti-inflammatory Agents Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 28. Asia-Pacific Anti-inflammatory Agents Growth Accelerators and Market Barriers

Table 29. Asia-Pacific Anti-inflammatory Agents Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 30. Central and South America Anti-inflammatory Agents Investment Opportunities and Key Challenges

Table 31. Central and South America Anti-inflammatory Agents Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 32. Middle East and Africa Anti-inflammatory Agents Investment Opportunities and Key Challenges

Table 33. Middle East and Africa Anti-inflammatory Agents Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 34. Thermo Fisher Scientific Inc Corporation Information

Table 35. Thermo Fisher Scientific Inc Description and Major Businesses

Table 36. Thermo Fisher Scientific Inc Product Features and Attributes

Table 37. Thermo Fisher Scientific Inc Revenue (US$ Million) and Gross Margin (2020-2025)

Table 38. Thermo Fisher Scientific Inc Revenue Proportion by Product in 2024

Table 39. Thermo Fisher Scientific Inc Revenue Proportion by Application in 2024

Table 40. Thermo Fisher Scientific Inc Revenue Proportion by Geographic Area in 2024

Table 41. Thermo Fisher Scientific Inc Anti-inflammatory Agents SWOT Analysis

Table 42. Thermo Fisher Scientific Inc Recent Developments

Table 43. Oracle Corporation Corporation Information

Table 44. Oracle Corporation Description and Major Businesses

Table 45. Oracle Corporation Product Features and Attributes

Table 46. Oracle Corporation Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. Oracle Corporation Revenue Proportion by Product in 2024

Table 48. Oracle Corporation Revenue Proportion by Application in 2024

Table 49. Oracle Corporation Revenue Proportion by Geographic Area in 2024

Table 50. Oracle Corporation Anti-inflammatory Agents SWOT Analysis

Table 51. Oracle Corporation Recent Developments

Table 52. Revvity, Inc Corporation Information

Table 53. Revvity, Inc Description and Major Businesses

Table 54. Revvity, Inc Product Features and Attributes

Table 55. Revvity, Inc Revenue (US$ Million) and Gross Margin (2020-2025)

Table 56. Revvity, Inc Revenue Proportion by Product in 2024

Table 57. Revvity, Inc Revenue Proportion by Application in 2024

Table 58. Revvity, Inc Revenue Proportion by Geographic Area in 2024

Table 59. Revvity, Inc Anti-inflammatory Agents SWOT Analysis

Table 60. Revvity, Inc Recent Developments

Table 61. Clario Corporation Information

Table 62. Clario Description and Major Businesses

Table 63. Clario Product Features and Attributes

Table 64. Clario Revenue (US$ Million) and Gross Margin (2020-2025)

Table 65. Clario Revenue Proportion by Product in 2024

Table 66. Clario Revenue Proportion by Application in 2024

Table 67. Clario Revenue Proportion by Geographic Area in 2024

Table 68. Clario Anti-inflammatory Agents SWOT Analysis

Table 69. Clario Recent Developments

Table 70. Illumina, Inc Corporation Information

Table 71. Illumina, Inc Description and Major Businesses

Table 72. Illumina, Inc Product Features and Attributes

Table 73. Illumina, Inc Revenue (US$ Million) and Gross Margin (2020-2025)

Table 74. Illumina, Inc Revenue Proportion by Product in 2024

Table 75. Illumina, Inc Revenue Proportion by Application in 2024

Table 76. Illumina, Inc Revenue Proportion by Geographic Area in 2024

Table 77. Illumina, Inc Anti-inflammatory Agents SWOT Analysis

Table 78. Illumina, Inc Recent Developments

Table 79. Qiagen NV Corporation Information

Table 80. Qiagen NV Description and Major Businesses

Table 81. Qiagen NV Product Features and Attributes

Table 82. Qiagen NV Revenue (US$ Million) and Gross Margin (2020-2025)

Table 83. Qiagen NV Recent Developments

Table 84. Agilent Technologies, Inc Corporation Information

Table 85. Agilent Technologies, Inc Description and Major Businesses

Table 86. Agilent Technologies, Inc Product Features and Attributes

Table 87. Agilent Technologies, Inc Revenue (US$ Million) and Gross Margin (2020-2025)

Table 88. Agilent Technologies, Inc Recent Developments

Table 89. IBM Corporation Corporation Information

Table 90. IBM Corporation Description and Major Businesses

Table 91. IBM Corporation Product Features and Attributes

Table 92. IBM Corporation Revenue (US$ Million) and Gross Margin (2020-2025)

Table 93. IBM Corporation Recent Developments

Table 94. Genedata AG Corporation Information

Table 95. Genedata AG Description and Major Businesses

Table 96. Genedata AG Product Features and Attributes

Table 97. Genedata AG Revenue (US$ Million) and Gross Margin (2020-2025)

Table 98. Genedata AG Recent Developments

Table 99. DNAnexus, Inc Corporation Information

Table 100. DNAnexus, Inc Description and Major Businesses

Table 101. DNAnexus, Inc Product Features and Attributes

Table 102. DNAnexus, Inc Revenue (US$ Million) and Gross Margin (2020-2025)

Table 103. DNAnexus, Inc Recent Developments

Table 104. Raw Materials Key Suppliers

Table 105. Distributors List

Table 106. Market Trends and Market Evolution

Table 107. Market Drivers and Opportunities

Table 108. Market Challenges, Risks, and Restraints

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

List of Figures

Figure 1. Anti-inflammatory Agents Product Picture

Figure 2. Global Anti-inflammatory Agents Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Software Product Picture

Figure 4. Services Product Picture

Figure 5. Global Anti-inflammatory Agents Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Pharmaceutical and Biotechnology Companies

Figure 7. Contract Research and Development Organizations

Figure 8. Others

Figure 9. Anti-inflammatory Agents Report Years Considered

Figure 10. Global Anti-inflammatory Agents Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Anti-inflammatory Agents Revenue (2020-2031) & (US$ Million)

Figure 12. Global Anti-inflammatory Agents Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 13. Global Anti-inflammatory Agents Revenue Market Share by Region (2020-2031)

Figure 14. Global Anti-inflammatory Agents Revenue Market Share Ranking (2024)

Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 16. Software Revenue Market Share by Player in 2024

Figure 17. Services Revenue Market Share by Player in 2024

Figure 18. Global Anti-inflammatory Agents Revenue Market Share by Type (2020-2031)

Figure 19. Global Anti-inflammatory Agents Revenue Market Share by Application (2020-2031)

Figure 20. North America Anti-inflammatory Agents Revenue YoY (2020-2031) & (US$ Million)

Figure 21. North America Top 5 Players Anti-inflammatory Agents Revenue (US$ Million) in 2024

Figure 22. North America Anti-inflammatory Agents Revenue (US$ Million) by Type (2020 - 2031)

Figure 23. North America Anti-inflammatory Agents Revenue (US$ Million) by Application (2020-2031)

Figure 24. US Anti-inflammatory Agents Revenue (2020-2031) & (US$ Million)

Figure 25. Canada Anti-inflammatory Agents Revenue (2020-2031) & (US$ Million)

Figure 26. Mexico Anti-inflammatory Agents Revenue (2020-2031) & (US$ Million)

Figure 27. Europe Anti-inflammatory Agents Revenue YoY (2020-2031) & (US$ Million)

Figure 28. Europe Top 5 Players Anti-inflammatory Agents Revenue (US$ Million) in 2024

Figure 29. Europe Anti-inflammatory Agents Revenue (US$ Million) by Type (2020-2031)

Figure 30. Europe Anti-inflammatory Agents Revenue (US$ Million) by Application (2020-2031)

Figure 31. Germany Anti-inflammatory Agents Revenue (2020-2031) & (US$ Million)

Figure 32. France Anti-inflammatory Agents Revenue (2020-2031) & (US$ Million)

Figure 33. U.K. Anti-inflammatory Agents Revenue (2020-2031) & (US$ Million)

Figure 34. Italy Anti-inflammatory Agents Revenue (2020-2031) & (US$ Million)

Figure 35. Russia Anti-inflammatory Agents Revenue (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Anti-inflammatory Agents Revenue YoY (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific Top 8 Players Anti-inflammatory Agents Revenue (US$ Million) in 2024

Figure 38. Asia-Pacific Anti-inflammatory Agents Revenue (US$ Million) by Type (2020-2031)

Figure 39. Asia-Pacific Anti-inflammatory Agents Revenue (US$ Million) by Application (2020-2031)

Figure 40. Indonesia Anti-inflammatory Agents Revenue (2020-2031) & (US$ Million)

Figure 41. Japan Anti-inflammatory Agents Revenue (2020-2031) & (US$ Million)

Figure 42. South Korea Anti-inflammatory Agents Revenue (2020-2031) & (US$ Million)

Figure 43. Australia Anti-inflammatory Agents Revenue (2020-2031) & (US$ Million)

Figure 44. India Anti-inflammatory Agents Revenue (2020-2031) & (US$ Million)

Figure 45. Indonesia Anti-inflammatory Agents Revenue (2020-2031) & (US$ Million)

Figure 46. Vietnam Anti-inflammatory Agents Revenue (2020-2031) & (US$ Million)

Figure 47. Malaysia Anti-inflammatory Agents Revenue (2020-2031) & (US$ Million)

Figure 48. Philippines Anti-inflammatory Agents Revenue (2020-2031) & (US$ Million)

Figure 49. Singapore Anti-inflammatory Agents Revenue (2020-2031) & (US$ Million)

Figure 50. Central and South America Anti-inflammatory Agents Revenue YoY (2020-2031) & (US$ Million)

Figure 51. Central and South America Top 5 Players Anti-inflammatory Agents Revenue (US$ Million) in 2024

Figure 52. Central and South America Anti-inflammatory Agents Revenue (US$ Million) by Type (2020-2031)

Figure 53. Central and South America Anti-inflammatory Agents Revenue (US$ Million) by Application (2020-2031)

Figure 54. Brazil Anti-inflammatory Agents Revenue (2020-2025) & (US$ Million)

Figure 55. Argentina Anti-inflammatory Agents Revenue (2020-2025) & (US$ Million)

Figure 56. Middle East and Africa Anti-inflammatory Agents Revenue YoY (2020-2031) & (US$ Million)

Figure 57. Middle East and Africa Top 5 Players Anti-inflammatory Agents Revenue (US$ Million) in 2024

Figure 58. South America Anti-inflammatory Agents Revenue (US$ Million) by Type (2020-2031)

Figure 59. Middle East and Africa Anti-inflammatory Agents Revenue (US$ Million) by Application (2020-2031)

Figure 60. GCC Countries Anti-inflammatory Agents Revenue (2020-2025) & (US$ Million)

Figure 61. Israel Anti-inflammatory Agents Revenue (2020-2025) & (US$ Million)

Figure 62. Egypt Anti-inflammatory Agents Revenue (2020-2025) & (US$ Million)

Figure 63. South Africa Anti-inflammatory Agents Revenue (2020-2025) & (US$ Million)

Figure 64. Anti-inflammatory Agents Industry Chain Mapping

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Celecoxib Market Insights Forecast to 2030

Global Nonsteroidal Anti Inflammatory Drugs NSAIDs Market Research Report 2024

Global Antiinflammatory Drugs Market Insights Forecast to 2030

Global Anti inflammatory Drugs for Dental Market Research Report 2024

Global Pets NSAIDs Market Research Report 2025

Global Cyclooxygenase 2 Inhibitor Market Research Report 2024

Anti inflammatory Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Analgesic and Anti inflammatory API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nonsteroidal Antiinflammatory Drugs Market Research Report 2025

Ibuprofen Injection Market

Cox 2 Inhibitors Market

Global Anti Rheumatic Drugs Market Research Report 2024

Global Tumor Necrosis Factor Alpha Inhibitors Market Research Report 2024

Global Pet NSAIDs Market Research Report 2025

Global Meloxicam Drugs Market Research Report 2024

Global Non Steroidal Anti Inflammatory Drugs NSAIDs Market Insights Forecast to 2030

Painkiller Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti inflammatory Therapeutics Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Global Anti Inflammatory Analgesic and Antipyretic Drugs Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions